UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 54

of 'Extravasation injury from chemotherapy and other non-antineoplastic vesicants'

54
TI
Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines.
AU
Jensen JN, Lock-Andersen J, Langer SW, Mejer J
SO
Scand J Plast Reconstr Surg Hand Surg. 2003;37(3):174.
 
Accidental extravasation of chemotherapy containing anthracycline often causes mutilating complications as a result of extensive tissue necrosis. Treatment therefore consists of extensive surgical debridement. We present the case of a 41-year-old woman with breast cancer who experienced extravasation of epirubicin. She was treated with an intravenous infusion of dexrazoxane for three successive days and recovered without surgical treatment and only slightly dysaesthesia in the surrounding tissue. Although infusion of dexrazoxane for this indication is still experimental we consider it a promising treatment for patients who have accidental extravasation of anthracyclines.
AD
Department of Plastic and Reconstructive Surgery, Roskilde University Hospital, Roskilde, Denmark.
PMID